Alcidion Group (ASX:ALC) signed a AU$5.5 million annual recurring subscription license contract with the Hywel Dda University Health Board in Wales for the use of its Miya Precision platform, according to a Tuesday Australian bourse filing.
The university health board will use Miya Precision for patient flow, observations and assessments, as well as a Smartpage for clinical communications and tasking.
The contract will last over five years, with an option to further extend for seven years for a total contract value of AU$7.7 million.
The company's shares rose past 5% in recent trading on Tuesday.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。